Differential expression of capillary VEGF isoforms following traumatic brain injury

REFERENCES

• Lim M, Cheshier S, Steinberg GK. New vessel formation in the central nervous system during tumor growth, vascular malforma-tions and Moyamoya. Curr Neurovasc Res 2006; 3: 237–245
   PubMed Web of Science ®Google Scholar
• LaManna JC, Chavez JC, Pichiule P. Structural and functional adaptation to hypoxia in the rat brain.] Exp Biol 2004; 207: 3163–3169
   PubMed Web of Science ®Google Scholar
• Hamik A, Wang B, Jain MK. Transcriptional regulators of angiogenesis. Arterioscler Thromb Vasc Biol 2006; 26: 1936–1947
   PubMed Web of Science ®Google Scholar
• Hayashi T, Deguchi K, Nagotani S, et al. Cerebral ischemia and angiogenesis. Curr Neurovasc Res 2006; 3: 119–129
   PubMed Web of Science ®Google Scholar
• Benelli R, Lorusso G, Albini A, et al. Cytokines and chemokines as regulators of angiogenesis in health and disease. Curr Pharm Des 2006; 12: 3101–3115
   PubMed Web of Science ®Google Scholar
• Ramsauer M, Krause D, Dermietzel R. Angiogenesis of the blood—brain barrier in vitro and the function of cerebral pericytes. FASEBJ 2002; 16: 1274–1276
   PubMed Web of Science ®Google Scholar
• Wakui S, Yokoo K, Muto T, et al. Localization of Ang-1, -2, Tie-2, and VEGF expression at endothelial-pericyte interdigitation in rat angiogenesis. Lab Invest 2006; 86: 1172–1184
   PubMed Web of Science ®Google Scholar
• Beckman JD, Grazul-Bilska AT, Johnson ML, et al. Isolation and characterization of ovine luteal pericytes and effects of nitric oxide on pericyte expression of angiogenic factors. Endocrine 2006; 29: 467–476
   PubMed Web of Science ®Google Scholar
• Bergers G, Song S. The role of pericytes in blood-vessel formation and maintenance. Neuro-oncol 2005; 7: 452–464
   PubMed Web of Science ®Google Scholar
• Armulik A, Abramsson A, Betsholz C. Endothelial/pericyte inter-actions. Circ Res 2005; 97: 512–523
   PubMed Web of Science ®Google Scholar
• Rundhaug JE. Matrix met al loproteinases and angiogenesis. J Cell Mol Med 2005; 9: 67–85
   Web of Science ®Google Scholar
• Sakurai S, Alam S, Pagan-Mercado G, et al. Retinal capillary pericyte proliferation and c-Fos mRNA induction by prostaglan-dins D2 through the camp response element. Invest Ophthalmol Vis Sci 2002; 43: 2774–2781
   PubMed Web of Science ®Google Scholar
• Diaz-Flores L, Gutierrez R, Valladares F, et al. Intense vascular sprouting form rat femoral vein induced by prostaglandins El and E2. Anat Rec 1994; 238: 68–76
   PubMedGoogle Scholar
• Wiley SR, Winkles JA. TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TWEAKR/Fn14 receptor. Cytokine Growth Factor Rev 2003; 14: 241–249
   PubMed Web of Science ®Google Scholar
• Marmarou A, Foda MA, van den Brink W, et al. A new model of diffuse brain injury in rats. Part I: Pathophysiology and biomecha-nics. J Neurosurg 1994; 80: 291–300
   PubMed Web of Science ®Google Scholar
• Dore-Duffy P, Washington R, Balabanov R. Cytokine-mediated activation of cultured CNS microvessels: A system for examining antigenic modulation of CNS endothelial cells and evidence for long-term expression of the adhesion protein E-selectin. J Cereb Blood Flow Metab 1994; 14: 837–844
   PubMed Web of Science ®Google Scholar
• Dore-Duffy P. Isolation and characterization of cerebral micro-vascular pericytes. Methods Mol Med 2003; 89: 375–382
   PubMedGoogle Scholar
• Seip WF, Evans GL. Atomospheric analysis and redox potentials of culture media in the GasPak System. J Clin Microbiol 1980; 11: 226–233
   PubMed Web of Science ®Google Scholar
• Dore-Duffy P, Owen C, Balabanov R, et al. Pericyte migration from the vascular wall in response to traumatic brain injury. Micro vasc Res 2000; 60: 55–69
   PubMed Web of Science ®Google Scholar
• Sobel AT, Branellec Al, Bianc CJ, et al. Physicochemical characterization of a vascular permeability factor produced by con A-stimulated human lymphocytes. J Immunol 1977; 119: 1230–1234
   PubMed Web of Science ®Google Scholar
• Lobb RR, Key ME, Alderman EM, et al. Partial purification and characterization of a vascular permeability factor secreted by a human colon adenocarcinoma cell line. Intl Cancer 1985; 36: 473–478
   PubMed Web of Science ®Google Scholar
• Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989; 161: 851–858
   PubMed Web of Science ®Google Scholar
• Rosenthal RA, Megavesi JF, Hanzel WJ, et al. Conditioned medium from mouse sarcoma 180 cells contains vascular endothelial growth factor. Growth Factors 1990; 4: 53–59
   PubMedGoogle Scholar
• Byrne AM, Bouchier-Hayes DJ, Harmey JH. Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J Cell Mol Med 2005; 9: 777–794
   PubMed Web of Science ®Google Scholar
• Balluan C, Wenimenger W, Uthman A, et al. Human keratinocytes express the three major splice forms of vascular endothelial growth factor. J Invest Dermatol 1995; 104: 7–10
   PubMed Web of Science ®Google Scholar
• Houck KA, Ferrara N, Winer J, et al. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 1991; 5: 1806–1814
   PubMed Web of Science ®Google Scholar
• Tober KL, Cannon RE, Spalding JW, et al. Comparative expression of novel vascular endothelial growth factor/vascular permeability factor transcripts in skin, papillomas, and carcinomas of v-Ha-ras Tg.AC transgenic mice and FVB/N mice. Biochem Biophys Res Commun 1998; 247: 644–653
   PubMed Web of Science ®Google Scholar
• Bates DO, Cui TG, Doughty JM, et al. VEGF165b, an inhibitory splice variant of vascular endothelial growth factor is down-regulated in renal cell carcinoma. Cancer Res 2002; 62: 4123–4131
   PubMed Web of Science ®Google Scholar
• Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nature 2003; 9: 669–676
   Web of Science ®Google Scholar
• Skold M, Von Geritten C, Sandberg-Nordqvist A, et al. VEGF and VEGF receptor expression after experimental brain contusion in rat. Neurotrauma 2005; 22: 353–367
   PubMed Web of Science ®Google Scholar
• Park JE, Keller GA, Ferrara N. The vascular endothelial growth factor (VEGF) isoforms: Differential deposition into the subepithe-lial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 1993; 4: 1317–1326
   PubMed Web of Science ®Google Scholar
• Cohen T, Gitay-Goren H, Saharon R, et al. VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparan binding ability, requires cell-surface heparin sulfates for efficient binding to the VEGF receptors of human melanoma cells. J Biol Chem 1995; 270: 11322–11326
   PubMed Web of Science ®Google Scholar
• Tessier S, Rockwell P, Hicklin D, et al. Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors. J Biol Chem 1994; 269: 12456–12461
   PubMed Web of Science ®Google Scholar
• Mohanraj D, Olson T, Ramakrishnan S. A novel method to purify recombinant vascular endothelial growth factor (VEGF121) expressed in yeast. Biochem Biophys Res Commun 1995; 215: 750–756
   PubMed Web of Science ®Google Scholar
• Gitay-Goren H, Cohen T, Tessier S, et al. Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells. J Biol Chem 1996; 271: 5519–5523
   PubMed Web of Science ®Google Scholar
• Houck KA, Leung DW, Rowland AM, et al. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 1992; 267: 26031–26037
   PubMed Web of Science ®Google Scholar
• Majone TE, levi BZ, Neufield G. Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechan ism. J Biol Chem 1995; 270: 15059–15065
   PubMed Web of Science ®Google Scholar
• Soker S, Gollamudi-Payne S, Fidder H, et al. Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial cell pro-liferation by a peptide corresponding to the exon 7-encoded domain of VEGF165. J Biol Chem 1997; 272: 31582–31588
   PubMed Web of Science ®Google Scholar
• Tian X, Wu J, Meng J. [Preparation of monoclonal antibodies to human vascular endothelial growth factor (VEGF121) and identi-fication of its expression on gastric carcinoma cell line (MGC8031)1. Zhonghua Zhong Liu Za Zhi 1999; 21: 93–95
   PubMedGoogle Scholar
• Ashikari-Hada S, Habuchi H, Kariya Y, et al. Heparin regulates vascular endothelial growth factor 165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells. Comparison of the effects of heparin and modified heparins. J Biol Chem 2005; 280: 31508–31515
   PubMed Web of Science ®Google Scholar
• Zhang HT, Scott PA, Morbidelli L, et al. The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo. Br] Cancer 2000; 83: 63–68
   PubMed Web of Science ®Google Scholar
• Ehrbar M, Dionov VG, Shcnell C, et al. Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth. Circ Res 2004; 94: 1124–1132
   PubMed Web of Science ®Google Scholar
• Poltorak Z, Cohen T, Sivan R, et al. VEGF145, A secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J Biol Chem 1997; 272: 7151–7158
   PubMed Web of Science ®Google Scholar
• Georges AL, Nugent MA. Regulation of vascular endothelial growth factor binding and activity by extracellular pH. J Biol Chem 2003; 278: 19518-19525
   PubMed Web of Science ®Google Scholar
• Barleon B, Sozzani S, Zhou D, et al. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor fit-1. Blood 1997; 87: 3336–3343
   Web of Science ®Google Scholar
• Dore-Duffy P, Katychev A, Wang X, et al. CNS microvascular pericytes exhibit multipotential stem cell activity. J Cereb Blood Flow Metab 2006; 26: 613–624
   PubMed Web of Science ®Google Scholar
• Mohamedali KA, Poblenz AT, Sikes CR, et al. Inhibition of prostate tumor growth and bone remodeling by the vascular targeting agent VEGF121/rGel. Cancer Res 2006; 66: 10919–10928
   PubMed Web of Science ®Google Scholar
• Maes C, Carmel iet P, Moermans D, et al. Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Mech Dev 2002; 111: 61–73
   PubMed Web of Science ®Google Scholar
• Mattot V, Moons L, Lupu F, et al. Loss of the VEGF(164) and VEGF(188) isoforms impairs postnatal glomerular angiogenesis and renal arteriogenesis in mice. J Am Soc Nephrol 2002; 13: 1548–1560
   PubMed Web of Science ®Google Scholar
• Galambos C, Ng YS, Ali A, et al. Defective pulmonary develop-ment in the absence of heparin-binding vascular endothelial growth factor isoforms. Am] Respir Cell Mol Biol 2002; 27: 194–203
   PubMed Web of Science ®Google Scholar
• Gowdak LH, Piliakova L, Wang X, et al. Adenovirus-mediated VEGF121 Gene transfer stimulates angiogenesis in normoperfused skelet al muscle and preserves tissue perfusion after induction of ischemia. Circulation 2000; 102: 565–571
   PubMed Web of Science ®Google Scholar
• Cheung CY, Brace RA. Ovine vascular endothelial growth factor: Nucleotide sequence and expression in fet al tissues. Growth Factors 1998; 16:11–22
   PubMed Web of Science ®Google Scholar
• Cheung CY, Brace RA. Developmental expression of vascular endothelial growth factor and its receptors in ovine placenta and fet al membranes. J Soc Gynecol Investig 1999; 6: 179–185
   PubMedGoogle Scholar
• Breier G, Albrecht U, Sterrer S, et al. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 1992; 114: 521–532
   PubMed Web of Science ®Google Scholar
• Ng YS, Rohan R, Sunday ME, et al. Differential expression of VEGF isoforms in mouse during development and in the adult. Dev Dyn 2001; 220: 112–121
   PubMed Web of Science ®Google Scholar
• Pichiule P, Agani F, Chavez JC, et al. HIF-1 alpha and VEGF expression after transient global cerebral ischemia. Adv Exp Med Biol 2003; 530: 611–617
   PubMed Web of Science ®Google Scholar
• Chodobski A, Chung I, Kozniewska E, et al. Early neutrophilic expression of vascular endothelial growth factor after traumatic brain injury. Neuroscience 2003; 122: 853–867
   PubMed Web of Science ®Google Scholar
• Shimizu T, Jayawardana BC, Tetsuka M, et al. Differential effect of follicle-stimulating hormone and estradiol on expressions of vascular endothelial growth factor (VEGF) 120, VEGF164 and their receptors in bovine granulosa cells. J Reprod Dev 2007; 53: 105–112
   PubMed Web of Science ®Google Scholar
• Brkovic A, Sirois MG. Vascular permeability induced by VEGF family members in vivo: Role of endogenous PAF and NO synthesis. Cell Biochem 2007; 100: 727–737
   PubMed Web of Science ®Google Scholar